Stapokibart, CAS 2734715-10-5

Product Description: Stapokibart (CM310) is a humanised monoclonal antibody targeting IL-4Rα and efficiently blocks the interaction of cytokines IL-4 and IL-13 with their co-receptor subunit IL-4Rα. Stapokibart has the capacity to interact with IL-4Rα in humans, cynomolgus monkeys, and rats[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Yuan Zhang, et al. Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial. EClinicalMedicine. 2023 Jul 5:61:102076.

CAS Number: 2734715-10-5

Molecular Weight: N/A

Compound Purity: 96.34

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P990093-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P990093-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK